US Government Ordered Carl-Gustaf Ammunition from Saab

STOCKHOLM, Sweden (BulgarianMilitary.com), June 29, 2018, Author: Galina Zdravkova, Photo credit: en.wikipedia.org

The photo shows a Carl Gustav recoilless rifle.

On Tuesday, 26th June 2018, Saab announced that the U.S. Department of Defense (DoD) has placed an ammunition order for its Carl-Gustaf man-portable weapon system. The order is at the amount of about $16 million, learned BulgarianMilitary.com

The deliveries under the new order are scheduled for the next year.

The ammunition order has been made under the H92222-14-D-0008 contract for the 84-mm recoilless rifle system, which is known in the USA as Multi-role, Anti-armor, Anti-personnel Weapon System (M3 MAAWS) announced with DoD in August 2014.

Besides the ammunition already used by the operators of the system, DoD has also ordered for the first time the MT 756 (Multi Target).

Michael Andersson, President and CEO of Saab North America, stated, “The Carl-Gustaf, with its broad range of munitions types, has repeatedly proven itself in the most demanding environments. With the addition of the MT 756 munition to the DoD inventory, warfighters will have even greater flexibility to customize the weapon and munitions load to their specific mission.”

The 84 mm MT 756 is intended for urban warfare. The MT 756 may penetrate hardened structures and affect the targets within thanks to a tandem charge.

The Carl Gustaf is an 84 mm man-portable anti-tank recoilless rifle produced by Saab Bofors Dynamics in Sweden. Most rounds fired by the Carl Gustaf work on the classic recoilless principle. Sometimes modern rounds add a post-firing booster that technically makes it a rocket launcher.

The Carl Gustaf M4 version is 3.4 kg lighter and shorter than the M3 MAAWS. These changes were made in response to the urban terrain peculiarities.

Read more: NDMA Places a Second Order for Saab’s Carl-Gustaf Ammunition

BulgarianMilitary.com

Comments
Loading...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More